Related Experiment Videos
Hürthle cell neoplasms of the thyroid
1Department of Surgery, University of Michigan Medical Center, Ann Arbor.
Otolaryngologic Clinics of North America
|June 1, 1990
Summary
Hürthle cell neoplasms of the thyroid require clear malignancy criteria. Benign lesions need lobectomy, while malignant ones necessitate total thyroidectomy for effective treatment.
Area of Science:
- Endocrinology
- Surgical Oncology
- Thyroid Pathology
Background:
- Hürthle cell neoplasms of the thyroid gland present diagnostic challenges.
- Lack of consensus on malignancy criteria complicates treatment strategies.
Purpose of the Study:
- To clarify diagnostic criteria for Hürthle cell neoplasms.
- To define appropriate surgical management based on lesion type.
Main Methods:
- Review of pathological features indicative of malignancy.
- Analysis of treatment outcomes for benign versus malignant Hürthle cell lesions.
Main Results:
- Malignancy is established by invasion into the thyroid capsule, blood vessels, contiguous neck structures, lymph nodes, or distant metastases.
- Benign Hürthle cell lesions are characterized by the absence of these invasive features.
Conclusions:
- Total lobectomy and isthmusectomy are recommended for benign Hürthle cell lesions.
- Total thyroidectomy is the standard treatment for malignant Hürthle cell lesions.